Abstract
Progressive Muscular Dystrophies (PMD) are clinically and genetically heterogeneous group of disorders for which there is no cure. The possibility to replace the defective muscle cells and improve muscular performance with cell therapy is a promising approach for the treatment of PMD, independently of the specific gene mutation. We recently compare the efficiency of two different sources …